Article info
Concise report
Targeted drug delivery by in vivo coupling to endogenous albumin: an albumin-binding prodrug of methotrexate (MTX) is better than MTX in the treatment of murine collagen-induced arthritis
- Dr E Neumann, Justus-Liebig-University Giessen, Department of Internal Medicine and Rheumatology, Kerckhoff-Klinik GmbH, Department of Rheumatology and Clinical Immunology, Benekestr 2-8, 61231 Bad Nauheim, Germany; e.neumann{at}kerckhoff-klinik.de
Citation
Targeted drug delivery by in vivo coupling to endogenous albumin: an albumin-binding prodrug of methotrexate (MTX) is better than MTX in the treatment of murine collagen-induced arthritis
Publication history
- Accepted March 29, 2008
- First published April 13, 2008.
Online issue publication
July 11, 2008
Article Versions
- Previous version (13 April 2008).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
2008 BMJ Publishing Group and European League Against Rheumatism